Table 1.
Characteristics and demographic data of subjects
| Characteristic (n = 17) | Value | Range |
|---|---|---|
| Age (years) | 62.7 ± 10.4 | 41.0–78.0 |
| Sex, n (%) | ||
| Male | 9 (52.9 %) | |
| Female | 8 (47.1 %) | |
| Height (cm) | 169.5 ± 6.6 | 160.0–183.0 |
| Body mass (kg) | 72.3 ± 10.0 | 57.5–90.0 |
| Body mass index (kg/m2) | 25.2 ± 3.2 | 20.2–33.1 |
| Type of stroke, n (%) | ||
| Ischaemic | 15 (88.2 %) | |
| Haemorrhagic | 2 (11.8 %) | |
| Hemiparetic side, n (%) | ||
| Left | 7 (41.2 %) | |
| Right | 10 (58.8 %) | |
| Stage, n (%) | ||
| Sub-acute | 6 (35.3 %) | |
| Chronic | 11 (64.7 %) | |
| Days post stroke, | 485.3 (535.5) | 21–1810 |
| median (IQR) | 350 (788) | |
| FAC | 3.6 ± 2.1 | 0–5 |
| NIHSS | 3.1 ± 3.2 | 0–11 |
| MMSE score | 28.1 ± 2.3 | 21–30 |
| Modified Rankin Scale | ||
| 0–2 | 12 (70.6 %) | |
| 3 | 1 (5.9 %) | |
| 4–5 | 4 (23.5 %) | |
| Comorbidities, n (%) | ||
| Hypertension | 9 (52.9 %) | |
| Diabetes mellitus | 1 (5.9 %) | |
| Dyslipidemia | 4 (23.5 %) | |
| None | 4 (23.5 %) | |
| Antihypertensive medications, n (%) | ||
| β-blocker | 2 (11.9 %) | |
| ACE inhibitors | 3 (17.6 %) | |
| Calcium channel blockers | 3 (17.6 %) | |
| None | 9 (52.9 %) | |
Values are mean ± SD unless otherwise indicated
Abbreviations: n number; SD standard deviation; MMSE Mini Mental State Examination; IQR interquartile range; FAC functional ambulation category; ACE angiotensin-converting-enzyme